Great Point Partners’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,621,333
Closed -$39.7M 47
2019
Q4
$39.7M Hold
2,621,333
3.46% 13
2019
Q3
$16.8M Buy
2,621,333
+1,068,433
+69% +$8.92M 1.54% 20
2019
Q2
$14.8M Buy
1,552,900
+52,900
+4% +$570K 1.65% 18
2019
Q1
$20.3M Buy
+1,500,000
New +$12.5M 2.01% 19
2018
Q1
Sell
-43,637
Closed -$1.21M 53
2017
Q4
$1.21M Buy
+43,637
New +$1.16M 0.21% 37
2017
Q1
Sell
-114,080
Closed -$3.46M 48
2016
Q4
$3.46M Sell
114,080
-565,323
-83% -$18.2M 0.71% 27
2016
Q3
$23M Sell
679,403
-120,597
-15% -$3.88M 5.86% 6
2016
Q2
$23.4M Buy
+800,000
New +$22.1M 6.7% 5

Great Point Partners's DERM Position: Q1 2020 in Review

Great Point Partners sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 2,621,333 shares — an estimated $39.7M sold.

Great Point Partners first reported a position in DERM in Q2 2016 and held it in 8 quarters. The position peaked at $39.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

  • Great Point Partners reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
  • Great Point Partners sold 2,621,333 Dermira, Inc. shares in Q1 2020, an estimated $39.7M.
  • Great Point Partners first reported a position in Dermira, Inc. in Q2 2016 and held it in 8 quarters.
  • Great Point Partners's Dermira, Inc. position peaked at $39.7M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Great Point Partners's 13F filing for Q1 2020, filed 15 May 2020.